Chromatin immunoprecipitation on microarray analysis of Smad2/3 binding sites reveals roles of ETS1 and TFAP2A in transforming growth factor β signaling

Molecular and Cellular Biology

Volumn 29, Issue 1, 2009, Pages 172-186

  Koinuma, Daizo ^a   Tsutsumi, Shuichi ^b   Kamimura, Naoko ^b   Taniguchi, Hirokazu ^e   Miyazawa, Keiji ^c   Sunamura, Makoto ^d,g   Imamura, Takeshi ^a   Miyazono, Kohei ^c,f   Aburatani, Hiroyuki ^b  

^a CANCER CHEMOTHERAPY CENTER   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e NATIONAL CANCER CENTER HOSPITAL   (Japan)

^f NONE   (Japan)

^g IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TUBULIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; GENE PRODUCT; LAMIN A; LAMIN B; NEUROSERPIN; PROTEIN ETS1; PROTEIN TFAP2A; SMAD2 PROTEIN; SMAD3 PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR AP 2; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; CDKN1A PROTEIN, HUMAN; ETS1 PROTEIN, HUMAN; PROTEIN C JUN; SMAD2 PROTEIN, HUMAN; SMAD3 PROTEIN, HUMAN; TFAP2A PROTEIN, HUMAN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR ETS 1;

ARTICLE; BINDING SITE; CDKN1A GENE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CYTOSTASIS; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN MICROARRAY; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; CELL DEATH; CELL LINE; DRUG EFFECT; GENE EXPRESSION PROFILING; GENE SILENCING; GENETIC TRANSCRIPTION; GENETICS; INTRON; METABOLISM; MICROARRAY ANALYSIS; TRANSCRIPTION INITIATION SITE; UPREGULATION;

BINDING SITES; CELL DEATH; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GENE EXPRESSION PROFILING; GENE KNOCKDOWN TECHNIQUES; HUMANS; INTRONS; MICROARRAY ANALYSIS; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEIN C-ETS-1; PROTO-ONCOGENE PROTEINS C-JUN; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTOR AP-2; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

EID: 58149468095     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.01038-08     Document Type: Article

References (57)

1. Akiyoshi, S., M. Ishii, N. Nemoto, M. Kawabata, H. Aburatani, and K. Miyazono. 2001. Targets of transcriptional regulation by transforming growth factor beta: expression profile analysis using oligonucleotide arrays. Jpn. J. Cancer Res. 92:257-268.
2. Boukamp, P., R. T. Petrussevska, D. Breitkreutz, J. Hornung, A. Markham, and N. E. Fusenig. 1988. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 106:761-771.
3. Carroll, J. S., C. A. Meyer, J. Song, W. Li, T. R. Geistlinger, J. Eeckhoute, A. S. Brodsky, E. K. Keeton, K. C. Fertuck, G. F. Hall, Q. Wang, S. Bekiranov, V. Sementchenko, E. A. Fox, P. A. Silver, T. R. Gingeras, X. S. Liu, and M. Brown. 2006. Genome-wide analysis of estrogen receptor binding sites. Nat. Genet. 38:1289-1297.
4. Chen, C. R., Y. Kang, P. M. Siegel, and J. Massague. 2002. E2F4/5 and p107 as Smad cofactors linking the TGF-β receptor to c-myc repression. Cell 110:19-32.
5. Chen, T. T., R. L. Wu, F. Castro-Munozledo, and T. T. Sun. 1997. Regulation of K3 keratin gene transcription by Sp1 and AP-2 in differentiating rabbit corneal epithelial cells. Mol. Cell. Biol. 17:3056-3064.
6. Chiefari, E., A. Brunetti, F. Arturi, J. M. Bidart, D. Russo, M. Schlumberger, and S. Filetti. 2002. Increased expression of AP2 and Sp1 transcription factors in human thyroid tumors: a role in NIS expression regulation? BMC Cancer 2:35.
7. Cordenonsi, M., S. Dupont, S. Maretto, A. Insinga, C. Imbriano, and S. Piccolo. 2003. Links between tumor suppressors: p53 is required for TGF-β gene responses by cooperating with Smads. Cell 113:301-314.
8. Crooks, G. E., G. Hon, J. M. Chandonia, and S. E. Brenner. 2004. WebLogo:a sequence logo generator. Genome Res. 14:1188-1190.
9. Czuwara-Ladykowska, J., V. I. Sementchenko, D. K. Watson, and M. Tro-janowska. 2002. Ets1 is an effector of the transforming growth factor β (TGF-β) signaling pathway and an antagonist of the profibrotic effects of TGF-β. J. Biol. Chem. 277:20399-20408.
10. Datto, M. B., Y. Yu, and X. F. Wang. 1995. Functional analysis of the transforming growth factor β responsive elements in the WAF1/Cip1/p21 promoter. J. Biol. Chem. 270:28623-28628.
11. Denissova, N. G., C. Pouponnot, J. Long, D. He, and F. Liu. 2000. Transforming growth factor β-inducible independent binding of SMAD to the Smad7 promoter. Proc. Natl. Acad. Sci. USA 97:6397-6402.
12. Dennis, G., Jr., B. T. Sherman, D. A. Hosack, J. Yang, W. Gao, H. C. Lane, and R. A. Lempicki. 2003. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. 4:P3.
13. Dennler, S., S. Itoh, D. Vivien, P. ten Dijke, S. Huet, and J.-M. Gauthier. 1998. Direct binding of Smad3 and Smad4 to critical TGF β-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 17:3091-3100.
14. Derynck, R., and Y. E. Zhang. 2003. Smad-dependent and Smad-indepen-dent pathways in TGF-β family signalling. Nature 425:577-584.
15. Dittmer, J. 2003. The biology of the Ets1 proto-oncogene. Mol. Cancer 2:29.
16. Ebisawa, T., K. Tada, I. Kitajima, K. Tojo, T. K. Sampath, M. Kawabata, K. Miyazono, and T. Imamura. 1999. Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation. J. Cell Sci. 112: 3519-3527.
17. Ehata, S., A. Hanyu, M. Hayashi, H. Aburatani, Y. Kato, M. Fujime, M. Saitoh, K. Miyazawa, T. Imamura, and K. Miyazono. 2007. Transforming growth factor-β promotes survival of mammary carcinoma cells through induction of antiapoptotic transcription factor DEC1. Cancer Res. 67:9694-9703.
18. Feng, X. H., and R. Derynck. 2005. Specificity and versatility in TGF-β signaling through Smads. Annu. Rev. Cell Dev. Biol. 21:659-693.
19. Frederick, J. P., N. T. Liberati, D. S. Waddell, Y. Shi, and X. F. Wang. 2004. Transforming growth factor 3 -mediated transcriptional repression of c-myc is dependent on direct binding of Smad3 to a novel repressive Smad binding element. Mol. Cell. Biol. 24:2546-2559.
20. 1 cyclins and cyclin-dependent protein kinases. Proc. Natl. Acad. Sci. USA 90:10315-10319.
21. Gomis, R. R., C. Alarcon, W. He, Q. Wang, J. Seoane, A. Lash, and J. Massague. 2006. A FoxO-Smad synexpression group in human keratino-cytes. Proc. Natl. Acad. Sci. USA 103:12747-12752.
22. Horak, C. E., M. C. Mahajan, N. M. Luscombe, M. Gerstein, S. M. Weiss-man, and M. Snyder. 2002. GATA-1 binding sites mapped in the β-globin locus by using mammalian chIp-chip analysis. Proc. Natl. Acad. Sci. USA 99:2924-2929.
23. Ji, X., W. Li, J. Song, L. Wei, and X. S. Liu. 2006. CEAS: cis-regulatory element annotation system. Nucleic Acids Res. 34:W551-W554.
24. Jiang, M. S., Q. Q. Tang, J. McLenithan, D. Geiman, W. Shillinglaw, W. J. Henzel, and M. D. Lane. 1998. Derepression of the C/EBPα gene during adipogenesis: identification of AP-2α as a repressor. Proc. Natl. Acad. Sci. USA 95:3467-3471.
25. Johnson, W. E., W. Li, C. A. Meyer, R. Gottardo, J. S. Carroll, M. Brown, and X. S. Liu. 2006. Model-based analysis of tiling-arrays for ChIP-chip. Proc. Natl. Acad. Sci. USA 103:12457-12462.
26. Jonk, L. J., S. Itoh, C. H. Heldin, P. ten Dijke, and W. Kruijer. 1998. Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-β, activin, and bone morphogenetic protein-inducible enhancer. J. Biol. Chem. 273:21145-21152.
27. Kaneshiro, K., S. Tsutsumi, S. Tsuji, K. Shirahige, and H. Aburatani. 2007. An integrated map of p53-binding sites and histone modification in the human ENCODE regions. Genomics 89:178-188.
28. Kang, Y., C. R. Chen, and J. Massague. 2003. A self-enabling TGF-β response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells. Mol. Cell 11:915-926.
29. Keeton, M. R., S. A. Curriden, A. J. van Zonneveld, and D. J. Loskutoff. 1991. Identification of regulatory sequences in the type 1 plasminogen activator inhibitor gene responsive to transforming growth factor β . J. Biol. Chem. 266:23048-23052.
30. Kim, J., K. Johnson, H. J. Chen, S. Carroll, and A. Laughon. 1997. Dro-sophila Mad binds to DNA and directly mediates activation of vestigial by Decapentaplegic. Nature 388:304-308.
31. Koinuma, D., M. Shinozaki, A. Komuro, K. Goto, M. Saitoh, A. Hanyu, M. Ebina, T. Nukiwa, K. Miyazawa, T. Imamura, and K. Miyazono. 2003.Arkadia amplifies TGF-β superfamily signalling through degradation of Smad7. EMBO J. 22:6458-6470.
32. Kretschmer, A., K. Moepert, S. Dames, M. Sternberger, J. Kaufmann, and A. Klippel. 2003. Differential regulation of TGF-β signaling through Smad2, Smad3 and Smad4. Oncogene 22:6748-6763.
33. Labbé, E., C. Silvestri, P. A. Hoodless, J. L. Wrana, and L. Attisano. 1998. Smad2 and Smad3 positivelyand negatively regulateTGF-β-dependent tran-scription through the forkhead DNA-binding protein FAST2. Mol. Cell 2:109-120.
34. Lazzaro, D., M. Price, M. de Felice, and R. Di Lauro. 1991. The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the foetal brain. Development 113:1093-1104.
35. Levy, L., and C. S. Hill. 2005. Smad4 dependency defines two classes of transforming growth factor β (TGF-β) target genes and distinguishes TGF-β -induced epithelial-mesenchymal transition from its antiproliferative and migratory responses. Mol. Cell. Biol. 25:8108-8125.
36. Li, J. M., P. P. Hu, X. Shen, Y. Yu, and X. F. Wang. 1997. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth fac-tor β through E2F binding sites. Proc. Natl. Acad. Sci. USA 94:4948-4953.
37. Lindemann, R. K., P. Ballschmieter, A. Nordheim, and J. Dittmer. 2001.Transforming growth factor β regulates parathyroid hormone-related protein expression in MDA-MB-231 breast cancer cells through a novel Smad/Ets synergism. J. Biol. Chem. 276:46661-46670.
38. Massagué, J., J. Seoane, and D. Wotton. 2005. Smad transcription factors. Genes Dev. 19:2783-2810.
39. Matys, V., E. Fricke, R. Geffers, E. Gossling, M. Haubrock, R. Hehl, K. Hornischer, D. Karas, A. E. Kel, O. V. Kel-Margoulis, D. U. Kloos, S. Land, B. Lewicki-Potapov, H. Michael, R. Munch, I. Reuter, S. Rotert, H. Saxel, M. Scheer, S. Thiele, and E. Wingender. 2003. TRANSFAC: transcriptional regulation, from patterns to profiles. Nucleic Acids Res. 31:374-378.
40. McPherson, L. A., G. W. Woodfield, and R. J. Weigel. 2007. AP2 transcription factors regulate expression of CRABPII in hormone responsive breast carcinoma. J. Surg. Res. 138:71-78.
41. Moustakas, A., and D. Kardassis. 1998. Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members. Proc. Natl. Acad. Sci. USA 95:6733-6738.
42. Nagarajan, R. P., J. Zhang, W. Li, and Y. Chen. 1999. Regulation of Smad7 promoter by direct association with Smad3 and Smad4. J. Biol. Chem. 274: 33412-33418.
43. Pardali, K., A. Kurisaki, A. Moren, P. ten Dijke, D. Kardassis, and A. Moustakas. 2000. Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-β. J. Biol. Chem. 275:29244-29256.
44. Ross, S., E. Cheung, T. G. Petrakis, M. Howell, W. L. Kraus, and C. S. Hill. 2006. Smads orchestrate specific histone modifications and chromatin remodeling to activate transcription. EMBO J. 25:4490-4502.
45. Seoane, J., H. V. Le, L. Shen, S. A. Anderson, and J. Massague. 2004. Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell 117:211-223.
46. Shirakihara, T., M. Saitoh, and K. Miyazono. 2007. Differential regulation of epithelial and mesenchymal markers by δEF1 proteins in epithelial mes-enchymal transition induced by TGF-β. Mol. Biol. Cell 18:3533-3544.
47. Siegel, P. M., and J. Massague. 2003. Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer. Nat. Rev. Cancer 3:807-821.
48. Siepel, A., G. Bejerano, J. S. Pedersen, A. S. Hinrichs, M. Hou, K. Rosen-bloom, H. Clawson, J. Spieth, L. W. Hillier, S. Richards, G. M. Weinstock, R. K. Wilson, R. A. Gibbs, W. J. Kent, W. Miller, and D. Haussler. 2005. Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res. 15:1034-1050.
49. Wendt, K. S., K. Yoshida, T. Itoh, M. Bando, B. Koch, E. Schirghuber, S. Tsutsumi, G. Nagae, K. Ishihara, T. Mishiro, K. Yahata, F. Imamoto, H. Aburatani, M. Nakao, N. Imamoto, K. Maeshima, K. Shirahige, and J. M. Peters. 2008. Cohesin mediates transcriptional insulation by CCCTC-binding factor. Nature 451:796-801.
50. Wong, C., E. M. Rougier-Chapman, J. P. Frederick, M. B. Datto, N. T. Liberati, J. M. Li, and X. F. Wang. 1999. Smad3-Smad4 and AP-1 complexes synergize in transcriptional activation of the c-Jun promoter by transforming growth factor β. Mol. Cell. Biol. 19:1821-1830.
51. Xi, Q., W. He, X. H. Zhang, H. V. Le, and J. Massague. 2008. Genome-wide impact of the BRG1 SWI/SNF chromatin remodeler on the transforming growth factor β transcriptional program. J. Biol. Chem. 283:1146-1155.
52. Yingling, J. M., M. B. Datto, C. Wong, J. P. Frederick, N. T. Liberati, and X. F. Wang. 1997. Tumor suppressor Smad4 is a transforming growth factor β-inducible DNA binding protein. Mol. Cell. Biol. 17:7019-7028.
53. Zavadil, J., M. Bitzer, D. Liang, Y. C. Yang, A. Massimi, S. Kneitz, E. Piek, and E. P. Bottinger. 2001. Genetic programs of epithelial cell plasticity directed by transforming growth factor-β. Proc. Natl. Acad. Sci. USA 98: 6686-6691.
54. Zawel, L., J. L. Dai, P. Buckhaults, S. Zhou, K. W. Kinzler, B. Vogelstein, and S. E. Kern. 1998. Human Smad3 and Smad4 are sequence-specific transcription activators. Mol. Cell 1:611-617.
55. Zeng, Y. X., K. Somasundaram, and W. S. el-Deiry. 1997. AP2 inhibits cancer cell growth and activates p21WAF1/CIP1 expression. Nat. Genet. 15:78-82.
56. Zhang, J., S. Hagopian-Donaldson, G. Serbedzija, J. Elsemore, D. Plehn-Dujowich, A. P. McMahon, R. A. Flavell, and T. Williams. 1996. Neuraltube, skeletal and body wall defects in mice lacking transcription factor AP-2. Nature 381:238-241.
57. Zhang, Y., X. H. Feng, and R. Derynck. 1998. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-β-induced transcription. Nature 394:909-913.